amgen meritade glp-1 activity duration Wants MariTide To Change Obesity Paradigm With Longer Dosing Periods Amgen CEO: There are a

IBD and autoimmune conditions This is the most significant concern

GLP-1 T2D (Type 2 Diabetes) indication market is primarily dominated by Novo Nordisk and Eli Lilly

Coverage usually requires prior authorization and documentation such as a confirmed diagnosis of type 2 diabetes, recent A1C results, and evidence that first-line treatments like metformin havent been effective

Br J Pharmacol 179(4):659676 Hernandez AF, Green JB, Janmohamed S, DAgostino Sr RB, Granger CB, Jones NP, et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Burns its best not to put off getting an orthopedic evaluation and possibly second opinions